NYSE American - Delayed Quote USD

Milestone Scientific Inc. (MLSS)

0.5400 -0.0110 (-2.00%)
At close: April 22 at 4:00 PM EDT
0.5350 -0.00 (-0.93%)
Pre-Market: 8:56 AM EDT
Loading Chart for MLSS
DELL
  • Previous Close 0.5510
  • Open 0.5400
  • Bid 0.5350 x 900
  • Ask 0.6000 x 800
  • Day's Range 0.5400 - 0.5750
  • 52 Week Range 0.5200 - 1.3500
  • Volume 131,659
  • Avg. Volume 77,664
  • Market Cap (intraday) 41.365M
  • Beta (5Y Monthly) 0.94
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1000
  • Earnings Date May 9, 2024 - May 13, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 3.00

Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.

www.milestonescientific.com

17

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MLSS

Performance Overview: MLSS

Trailing total returns as of 4/22/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

MLSS
21.74%
S&P 500
5.05%

1-Year Return

MLSS
27.03%
S&P 500
21.22%

3-Year Return

MLSS
78.23%
S&P 500
20.06%

5-Year Return

MLSS
42.11%
S&P 500
72.48%

Compare To: MLSS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MLSS

Valuation Measures

Annual
As of 4/22/2024
  • Market Cap

    41.37M

  • Enterprise Value

    35.81M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.00

  • Price/Book (mrq)

    5.16

  • Enterprise Value/Revenue

    3.64

  • Enterprise Value/EBITDA

    -5.15

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -70.51%

  • Return on Assets (ttm)

    -35.43%

  • Return on Equity (ttm)

    -77.49%

  • Revenue (ttm)

    9.83M

  • Net Income Avi to Common (ttm)

    -6.93M

  • Diluted EPS (ttm)

    -0.1000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.95M

  • Total Debt/Equity (mrq)

    4.94%

  • Levered Free Cash Flow (ttm)

    -3.23M

Research Analysis: MLSS

Analyst Price Targets

3.00
3.00 Average
0.5400 Current
3.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: MLSS

Fair Value

0.5400 Current
 

Dividend Score

0 Low
MLSS
Sector Avg.
100 High
 

Hiring Score

0 Low
MLSS
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
MLSS
Sector Avg.
100 High
 

People Also Watch